Strength
300 mg/1
Manufacturer
AvPAKNDC
50268075812
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090742On Market Since
3/30/2020
Pharmacological Classes
Price Statistics
The NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has been published 312 times since Jul 8, 2020, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3107 per EA |
|---|---|
| All-time high | $0.9854 (Jul 15, 2020) |
| All-time low | $0.3107 (Jun 17, 2026) |
| 52-week high | $0.4227 |
| 52-week low | $0.3107 |
| Median price | $0.4919 |
| Average price | $0.5432 |
| Largest weekly change | -41.2% (Oct 20, 2021) |
| Weeks tracked | 312 |
| Tracking since | Jul 8, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, manufactured by AvPAK, is $0.3107 per EA (NDC 50268075812), effective Jun 24, 2026.
How has the price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has declined 68.5%. It has been tracked across 312 weekly CMS publications since Jul 8, 2020.
What are the highest and lowest recorded NADAC prices for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
Since Jul 8, 2020, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has ranged from a low of $0.3107 (Jun 17, 2026) to a high of $0.9854 (Jul 15, 2020), with a median of $0.4919 per EA.
Are there cheaper alternatives to TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, but none are currently priced below it.
Who manufactures TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (NDC 50268075812) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification